The Correlation Between Sarcopenia And Transthyretin Levels Among Community-Dwelling Older Adults In Padang, West Sumatra

Authors

  • R. Ifan Arief Fahrurozi Faculty of Medicine, Andalas University
  • Rose Dinda Martini Faculty of Medicine, Andalas University
  • Roza Mulyana Faculty of Medicine, Andalas University
  • Fandi Triansyah Faculty of Medicine, Andalas University

DOI:

https://doi.org/10.59188/eduvest.v4i11.49959

Keywords:

Sarcopenia, transthyretin, malnutrition

Abstract

The objective of this study was to evaluate the correlation between sarcopenia and transthyretin levels among community-dwelling older adults in Padang. This study employed a cross-sectional design and included 45 community-dwelling individuals aged 60 years and above who visited Andalas Primary Health Care in Padang, West Sumatra, Indonesia. Characteristics of sociodemographic and lifestyle habits were collected using a general questionnaire. Sarcopenia was defined in accordance with the criteria set forth by the Asian Working Group for Sarcopenia (AWGS) criteria encompass three components: low muscle mass, as determined by an index of appendicular skeletal mass/height2 less than 7,0 kg/m2 for males and less than 5,7 kg/m2 for females; low physical performance, as indicated by a gait speed less than 1,0 m/s; low muscle strength, defined as handgrip strength less than 26 kg for males and less than 18 kg for females. Accordingly, sarcopenia was defined as the presence of low muscle mass in conjunction with low physical performance and/or low muscle strength. Transthyretin levels were considered as independent variables in order to evaluate the potential correlation between transthyretin and sarcopenia status using bivariate analysis.  The overall prevalence of sarcopenia was 51.1%, with four cases (40%) observed in males and 19 cases (54.3%) in females classified as having sarcopenia. The prevalence of sarcopenia was significantly lower among participants with normal nutritional status. A comparison of the participants with and without sarcopenia revealed that the former exhibited higher levels of transthyretin (p = 0,000).

References

Amarya, S., Singh, K., & Sabharwal, M. (2018). Ageing process and physiological changes. In Gerontology. IntechOpen.

Aryana, I. G. P. S. (2021). Sarkopenia pada Lansia: Problem Diagnosis dan Tatalaksana. Baswara Press.

Beaudart, C., Rizzoli, R., Bruyère, O., Reginster, J.-Y., & Biver, E. (2014). Sarcopenia: burden and challenges for public health. Archives of Public Health, 72, 1–8.

Beaudart, C., Sanchez-Rodriguez, D., Locquet, M., Reginster, J.-Y., Lengelé, L., & Bruyère, O. (2019). Malnutrition as a strong predictor of the onset of sarcopenia. Nutrients, 11(12), 2883.

Black, K. E., & Matkin-Hussey, P. (2024). The Impact of Protein in Post-Menopausal Women on Muscle Mass and Strength: A Narrative Review. Physiologia, 4(3), 266–285.

Boshnjaku, A., & Krasniqi, E. (2024). Diagnosing sarcopenia in clinical practice: International guidelines vs. population-specific cutoff criteria. Frontiers in Medicine, 11, 1405438.

Bruyère, O., Beaudart, C., Ethgen, O., Reginster, J.-Y., & Locquet, M. (2019). The health economics burden of sarcopenia: a systematic review. Maturitas, 119, 61–69.

Budiartha, I. G. A. I. M., Aryana, I. G. P. S., Purnami, N. K. R., Putrawan, I. B., AStika, I. N., & Kuswardhani, R. A. T. (2019). Hubungan massa otot pada sarkopenia dengan status fungsional lanjut usia di desa Pedawa, kabupaten Buleleng, Bali. Jurnal Penyakit Dalam Udayana, 3(2), 37–39.

Cederholm, T., Bosaeus, I., Barazzoni, R., Bauer, J., Van Gossum, A., Klek, S., Muscaritoli, M., Nyulasi, I., Ockenga, J., & Schneider, S. M. (2015). Diagnostic criteria for malnutrition–an ESPEN consensus statement. Clinical Nutrition, 34(3), 335–340.

Chen, Q., Hao, Q., Ding, Y., & Dong, B. (2019). The association between sarcopenia and prealbumin levels among elderly Chinese inpatients. The Journal of Nutrition, Health and Aging, 23(2), 122–127.

Cruz-Jentoft, A. J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T., Cooper, C., Landi, F., Rolland, Y., & Sayer, A. A. (2019). Sarcopenia: revised European consensus on definition and diagnosis. Age and Ageing, 48(1), 16–31.

Dewiasty, E., Agustina, R., Saldi, S. R. F., Pramudita, A., Hinssen, F., Kumaheri, M., De Groot, L. C., & Setiati, S. (2022). Malnutrition prevalence and nutrient intakes of Indonesian community-dwelling older adults: a systematic review of observational studies. Frontiers in Nutrition, 9, 780003.

Eglseer, D., Eminovic, S., & Lohrmann, C. (2016). Association between sarcopenia and nutritional status in older adults: a systematic literature review. Journal of Gerontological Nursing, 42(7), 33–41.

Gao, Q., Hu, K., Yan, C., Zhao, B., Mei, F., Chen, F., Zhao, L., Shang, Y., Ma, Y., & Ma, B. (2021). Associated factors of sarcopenia in community-dwelling older adults: a systematic review and meta-analysis. Nutrients, 13(12), 4291.

Goates, S., Du, K., Arensberg, M. B., Gaillard, T., Guralnik, J., & Pereira, S. L. (2019). Economic impact of hospitalizations in US adults with sarcopenia. The Journal of Frailty & Aging, 8, 93–99.

Harimurti, K., Setiati, S., Soejono, C. H., Aryana, I. G. P. S., Sunarti, S., Budiningsih, F., Mulyana, R., Dwipa, L., Sudarso, A., & Rensa, R. (2023). Sarcopenia in a Multiethnic State: A Cross-Sectional Data Analysis of Multicentre Indonesia Longitudinal Aging Study. Acta Medica Indonesiana, 55(1), 61–69.

Ingenbleek, Y. (2019). Plasma transthyretin as a biomarker of sarcopenia in elderly subjects. Nutrients, 11(4), 895.

Ingenbleek, Y. (2023). Revisiting PINI scoring in light of recent biological advances. Nutrients, 15(8), 1846.

Jang, J. Y., Kim, D., & Kim, N. D. (2023). Pathogenesis, intervention, and current status of drug development for sarcopenia: a review. Biomedicines, 11(6), 1635.

Keller, U. (2019). Nutritional laboratory markers in malnutrition. Journal of Clinical Medicine, 8(6), 775.

Larsson, L., Degens, H., Li, M., Salviati, L., Lee, Y. Il, Thompson, W., Kirkland, J. L., & Sandri, M. (2019). Sarcopenia: aging-related loss of muscle mass and function. Physiological Reviews, 99(1), 427–511.

Liz, M. A., Coelho, T., Bellotti, V., Fernandez-Arias, M. I., Mallaina, P., & Obici, L. (2020). A narrative review of the role of transthyretin in health and disease. Neurology and Therapy, 9(2), 395–402.

Lu, Y., Karagounis, L. G., Ng, T. P., Carre, C., Narang, V., Wong, G., Tan, C. T. Y., Zin Nyunt, M. S., Gao, Q., & Abel, B. (2020). Systemic and metabolic signature of sarcopenia in community-dwelling older adults. The Journals of Gerontology: Series A, 75(2), 309–317.

Mellen, R. H., Girotto, O. S., Marques, E. B., Laurindo, L. F., Grippa, P. C., Mendes, C. G., Garcia, L. N. H., Bechara, M. D., Barbalho, S. M., & Sinatora, R. V. (2023). Insights into pathogenesis, nutritional and drug approach in sarcopenia: a systematic review. Biomedicines, 11(1), 136.

Mitchell, W. K., Williams, J., Atherton, P., Larvin, M., Lund, J., & Narici, M. (2012). Sarcopenia, dynapenia, and the impact of advancing age on human skeletal muscle size and strength; a quantitative review. Frontiers in Physiology, 3, 260.

Njoto, E. N., & Suka Aryana, I. (2023). Sarkopenia pada Lanjut Usia: Patogenesis, Diagnosis dan Tata Laksana. Jurnal Penyakit Dalam Indonesia, 10(3), 9.

Norman, K., Haß, U., & Pirlich, M. (2021). Malnutrition in older adults—recent advances and remaining challenges. Nutrients, 13(8), 2764.

Ribeiro, S. M. L., & Kehayias, J. J. (2014). Sarcopenia and the analysis of body composition. Advances in Nutrition, 5(3), 260–267.

Rogeri, P. S., Zanella Jr, R., Martins, G. L., Garcia, M. D. A., Leite, G., Lugaresi, R., Gasparini, S. O., Sperandio, G. A., Ferreira, L. H. B., & Souza-Junior, T. P. (2021). Strategies to prevent sarcopenia in the aging process: role of protein intake and exercise. Nutrients, 14(1), 52.

Sato, P. H. R., Ferreira, A. A., & Rosado, E. L. (2020). The prevalence and risk factors for sarcopenia in older adults and long-living older adults. Archives of Gerontology and Geriatrics, 89, 104089.

Sayer, A. A., & Cruz-Jentoft, A. (2022). Sarcopenia definition, diagnosis and treatment: consensus is growing. Age and Ageing, 51(10), afac220.

Shokri-Mashhadi, N. (2023). Perspective Chapter: The Role of Modifiable Factors, Particularly Nutritional Factors, on Age-Related Sarcopenia. In Geriatric Medicine and Healthy Aging. IntechOpen.

Sieber, C. C. (2019). Malnutrition and sarcopenia. Aging Clinical and Experimental Research, 31, 793–798.

Sumandar, S., Ekaputri, M., & Ramadia, A. (2023). Sarcopenia: The Prevalence and Associated Factors in Community-Dwelling Elderly. Media Kesehatan Masyarakat Indonesia, 19(2), 50–60.

Wardhana, D. M., Widajanti, N., & Ichwani, J. (2019). Hubungan Komponen Comprehensive Geriatric. Jurnal Penyakit Dalam Indonesia| Vol, 6(4).

Widajanti, N., Ichwani, J., Dharmanta, R. S., Firdausi, H., Haryono, Y., Yulianti, E., Kandinata, S. G., Wulandari, M., Widyasari, R., & Adyanita, V. A. (2020). Sarcopenia and frailty profile in the elderly community of Surabaya: a descriptive study. Acta Medica Indonesiana, 52(1), 5–13.

Xiu, S., Sun, L., Mu, Z., & Fu, J. (2021). Low prealbumin levels are associated with sarcopenia in older men with type 2 diabetes mellitus: A cross-sectional study. Nutrition, 91, 111415.

Xu, B., Guo, Z., Jiang, B., Zhang, K., Zhu, W., Lian, X., Xu, Y., Zhao, Z., & Liu, L. (2022). Factors affecting sarcopenia in older patients with chronic diseases. Annals of Palliative Medicine, 11(3), 97283–97983.

Xu, Y., Deng, K.-L., Xing, T.-F., Mei, Y.-Q., & Xiao, S.-M. (2020). Effect of hormone therapy on muscle strength in postmenopausal women: a systematic review and meta-analysis of randomized controlled trials. Menopause, 27(7), 827–835.

Yang, Y., Zhang, Q., He, C., Chen, J., Deng, D., Lu, W., & Wang, Y. (2022). Prevalence of sarcopenia was higher in women than in men: a cross-sectional study from a rural area in eastern China. PeerJ, 10, e13678.

Yerrakalva, D., Hajna, S., Khaw, K.-T., Griffin, S. J., & Brage, S. (2024). Prospective associations between changes in physical activity and sedentary time and subsequent lean muscle mass in older English adults: the EPIC-Norfolk cohort study. International Journal of Behavioral Nutrition and Physical Activity, 21(1), 10.

Yuan, S., & Larsson, S. C. (2023). Epidemiology of sarcopenia: Prevalence, risk factors, and consequences. Metabolism, 144, 155533.

Downloads

Published

2024-12-10

How to Cite

Arief Fahrurozi, R. I., Martini, R. D., Mulyana, R., & Triansyah, F. . (2024). The Correlation Between Sarcopenia And Transthyretin Levels Among Community-Dwelling Older Adults In Padang, West Sumatra. Eduvest - Journal of Universal Studies, 4(11), 10957–10969. https://doi.org/10.59188/eduvest.v4i11.49959